Johnson & Johnson
NYSE:JNJ
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
144.38
174.01
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. [ Read More ]
The intrinsic value of one JNJ stock under the Base Case scenario is hidden USD. Compared to the current market price of 158.39 USD, Johnson & Johnson is hidden .
Valuation Backtest
Johnson & Johnson
Run backtest to discover the historical profit from buying and selling JNJ based on its intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Johnson & Johnson
Current Assets | 57.8B |
Cash & Short-Term Investments | 25.5B |
Receivables | 15.8B |
Other Current Assets | 16.5B |
Non-Current Assets | 123.3B |
Long-Term Investments | 470m |
PP&E | 19.7B |
Intangibles | 84B |
Other Non-Current Assets | 19.1B |
Current Liabilities | 53.9B |
Accounts Payable | 8.8B |
Accrued Liabilities | 30.9B |
Short-Term Debt | 8.5B |
Other Current Liabilities | 5.7B |
Non-Current Liabilities | 55.6B |
Long-Term Debt | 31.6B |
Other Non-Current Liabilities | 24B |
Earnings Waterfall
Johnson & Johnson
Revenue
|
86.6B
USD
|
Cost of Revenue
|
-26.5B
USD
|
Gross Profit
|
60.1B
USD
|
Operating Expenses
|
-35.2B
USD
|
Operating Income
|
24.9B
USD
|
Other Expenses
|
13.1B
USD
|
Net Income
|
38B
USD
|
Free Cash Flow Analysis
Johnson & Johnson
USD | |
Free Cash Flow | USD |
Johnson & Johnson's second quarter of 2024 showcased robust performance, driven by strong sales and innovative milestones. Worldwide sales reached $22.4 billion, marking a 6.6% increase, with notable contributions from key products in oncology and immunology. The company's net earnings were $4.7 billion, with adjusted earnings per share up by 10.2% to $2.82. Their Innovative Medicine segment grew by 7.8%, while MedTech sales increased by 4.4%. J&J projects full-year operational sales growth between 6.1% and 6.6%, adjusting EPS guidance to $10-$10.10 per share, reflecting recent strategic acquisitions【4:0†source】.
What is Earnings Call?
JNJ Profitability Score
Profitability Due Diligence
Johnson & Johnson's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Johnson & Johnson's profitability score is hidden . The higher the profitability score, the more profitable the company is.
JNJ Solvency Score
Solvency Due Diligence
Johnson & Johnson's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Johnson & Johnson's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
JNJ Price Targets Summary
Johnson & Johnson
According to Wall Street analysts, the average 1-year price target for JNJ is 174.9 USD with a low forecast of 151.5 USD and a high forecast of 225.75 USD.
Shareholder Yield
Current shareholder yield for JNJ is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
JNJ Price
Johnson & Johnson
Average Annual Return | 10.7% |
Standard Deviation of Annual Returns | 3.09% |
Max Drawdown | -27% |
Market Capitalization | 381.2B USD |
Shares Outstanding | 2 407 239 936 |
Percentage of Shares Shorted | 0.75% |
Ownership
JNJ Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in New Brunswick, New Jersey and currently employs 141,700 full-time employees. The firm operates through three segments: Consumer Health, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.
Contact
IPO
Employees
Officers
The intrinsic value of one JNJ stock under the Base Case scenario is hidden USD.
Compared to the current market price of 158.39 USD, Johnson & Johnson is hidden .